These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 461278)

  • 21. Serological response to whole, split and subunit influenza vaccines of persons with and without immunological experience towards influenza A/U.S.S.R. 90/77 virus.
    Sarateanu DE; Ehrengut W; Pressler K; Peukert M; Schenk KD
    Comp Immunol Microbiol Infect Dis; 1980; 3(1-2):225-36. PubMed ID: 7471712
    [No Abstract]   [Full Text] [Related]  

  • 22. [Formation and protective functions of antibodies to neuraminidase of the influenza A virus].
    Naĭkhin AN; Tsaritsyna IM; Oleĭnikova EV; Ismagulov AT; Reznik VI
    Vopr Virusol; 1985; 30(1):35-9. PubMed ID: 3993000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From Original Antigenic Sin to the Universal Influenza Virus Vaccine.
    Henry C; Palm AE; Krammer F; Wilson PC
    Trends Immunol; 2018 Jan; 39(1):70-79. PubMed ID: 28867526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Swine influenza virus and the recycling of influenza-A viruses in man.
    Masurel N
    Lancet; 1976 Jul; 2(7979):244-7. PubMed ID: 59252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of purified influenza subunit vaccines and relation to the major antigenic determinants on the hemagglutinin molecule.
    Couch RB; Webster RG; Kasel JA; Cate TR
    J Infect Dis; 1979 Oct; 140(4):553-9. PubMed ID: 92511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection.
    Oxford JS; Schild GC; Potter CW; Jennings R
    J Hyg (Lond); 1979 Feb; 82(1):51-61. PubMed ID: 105040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Monoreceptor antibodies to the hemagglutinin antigenic determinants of influenza viruses H2N2 and their virus-neutralizing activity].
    Ismaĭlova IM; Isaeva EI; Rovnova ZI
    Vopr Virusol; 1985; 30(1):115-9. PubMed ID: 2581366
    [No Abstract]   [Full Text] [Related]  

  • 28. Variant-specific antihemagglutinin serum response to type A influenza natural infection and inactivated vaccines in adults.
    Kasel JA; Six HR; Couch RB; Greenberg SB; Cate TR
    Proc Soc Exp Biol Med; 1979 Sep; 161(4):519-21. PubMed ID: 90369
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinico-immunologic and allergologic studies with the inactivated influenza virus vaccine purified and concentrated by gradient centrifugation.
    Subbotina TI; Tenkova TV; Sidorova LV; Shpilyuk GF; Drinevsky VP; Voitsekhovskaya EM; Konstantinov VK; Sominina AA
    Acta Virol; 1988 Nov; 32(6):494-502. PubMed ID: 2906221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. II. Sequential infection of mice simulates human experience.
    Johansson BE; Moran TM; Bona CA; Popple SW; Kilbourne ED
    J Immunol; 1987 Sep; 139(6):2010-4. PubMed ID: 3624874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody response of young adults to experimental influenza A/New Jersey/76 virus vaccines.
    Meiklejohn G; Eickhoff TC; Graves P
    J Infect Dis; 1977 Dec; 136 Suppl():S456-9. PubMed ID: 606766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serologic survey of human type A influenza virus infection following 10-year periods of prevalence of H3N2 strains].
    Profeta ML; De Vito D; Fasan M
    Boll Ist Sieroter Milan; 1979 Jan; 57(6):690-9. PubMed ID: 552822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic variation of recent influenza A(H3N2) viruses.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Jan; 37(3):38-40, 46-7. PubMed ID: 3122010
    [No Abstract]   [Full Text] [Related]  

  • 34. Human trials with wild-type H1N1 and recombinant H3N2-H1N1 influenza A viruses of 1977-1978.
    Beare AS; Kendal AP; Cox NJ; Scholtissek C
    Infect Immun; 1980 Jun; 28(3):753-61. PubMed ID: 7399693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leads from the MMWR. Antigenic variation of recent influenza A(H3N2) viruses.
    JAMA; 1988 Feb; 259(7):972, 975. PubMed ID: 3339810
    [No Abstract]   [Full Text] [Related]  

  • 36. Human sera possess a limited antibody repertoire to influenza neuraminidase antigenic variants selected in vitro.
    Natali A; Panizzi PF; Chezzi C; Oxford JS
    J Hyg (Lond); 1984 Apr; 92(2):243-50. PubMed ID: 6707473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antineuraminidase serum antibodies in natural influenza A and immunization with influenza vaccines].
    Naĭkhin AN; Tsaritsyna IM; Syrodoeva LG; Oleĭnikova EV; Gorev NE
    Vopr Virusol; 1983; (2):154-9. PubMed ID: 6868553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
    Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M
    Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigenic analysis of recent H1N1 influenza viruses with monoclonal antibodies.
    Yamada A; Cao MS; Imanishi J; Oyama S; Abe A; Katagiri S
    Acta Virol; 1991 Aug; 35(4):343-9. PubMed ID: 1724874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influenza vaccine stimulation of antibodies to different variants of influenza A virus].
    Naĭkhin AN; Ispolatova AV; Tsybul'skaia NV; Sominina AA; Denisov GM
    Vopr Virusol; 1985; 30(3):290-6. PubMed ID: 4049840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.